Syqe Medical is a private Israeli company that has developed an inhaler enabling the precise delivery of botanicals (including cannabis) at the level of safety and precision of conventional drugs.

The company’s product answers a significant unmet need in the medicinal cannabis market. Lack of accurate precise dosing capabilities, physician control, associated stigma and quality control are the major obstacles which make it difficult for doctors to prescribe and monitor medicinal cannabis treatment for their patients.

The company’s technology has been validated through clinical trials which demonstrate the inhaler’s precision, compliance with pharmaceutical standards for the delivery of inhaled cannabis, and strategic partnership and commercial agreements reached with first-tier international players.